{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:01:21Z","timestamp":1785852081004,"version":"3.56.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,11,27]]},"DOI":"10.1097\/01.tp.0000141363.81600.0d","type":"journal-article","created":{"date-parts":[[2004,11,17]],"date-time":"2004-11-17T04:03:13Z","timestamp":1100664193000},"page":"1515-1522","source":"Crossref","is-referenced-by-count":33,"title":["Thrombotic Microangiopathy after Allogeneic Blood and Marrow Transplantation Is Associated with Dose-Intensive Myeloablative Conditioning Regimens, Unrelated Donor, and Methylprednisolone T-Cell Depletion"],"prefix":"10.1097","volume":"78","author":[{"given":"Theresa","family":"Hahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif Raza","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LaurieAnn","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zale P.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron S.","family":"Czuczman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Slack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir","family":"Wetzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210129","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","article-title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: A diagnostic dilemma.","volume":"44","author":"George","year":"2004","journal-title":"Transfusion"},{"key":"R2-16-20210129","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-0038-1642684","article-title":"Thrombotic thrombocytopenic purpura.","volume":"74","author":"Moake","year":"1995","journal-title":"Thromb Haemost"},{"key":"R3-16-20210129","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1600-0609.1996.tb01930.x","article-title":"The pathophysiology and management of thrombotic thrombocytopenic purpura.","volume":"56","author":"Ruggenenti","year":"1996","journal-title":"Eur J Haematol"},{"key":"R4-16-20210129","first-page":"178","article-title":"The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infusions and plasma exchange.","volume":"24","author":"Shepard","year":"1987","journal-title":"Semin Hematol"},{"key":"R5-16-20210129","first-page":"159","article-title":"Management of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.","volume":"34","author":"Kwaan","year":"1997","journal-title":"Semin Hematol"},{"key":"R6-16-20210129","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0002-9610(99)80015-4","article-title":"Thrombotic thrombocytopenic purpura: Indications for and results of splenectomy.","volume":"170","author":"Winslow","year":"1995","journal-title":"Am J Surg"},{"key":"R7-16-20210129","first-page":"81","article-title":"Pilot study of combined cryosupernatant and protein A immunoadsorption exchange in the treatment of grade 3\u20134 bone marrow transplant associated thrombotic microangiopathy.","volume":"17","author":"Zeigler","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"R8-16-20210129","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1182\/blood.V72.2.451.451","article-title":"Intravascular hemolysis and renal insufficiency after bone marrow transplantation.","volume":"72","author":"Guinan","year":"1988","journal-title":"Blood"},{"key":"R9-16-20210129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/07357909609018890","article-title":"Thrombotic microangiopathic syndromes after bone marrow transplantation.","volume":"14","author":"Byrnes","year":"1996","journal-title":"Cancer Invest"},{"key":"R10-16-20210129","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2141.2001.02699.x","article-title":"The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation.","volume":"113","author":"Fuge","year":"2001","journal-title":"Br J Haematol"},{"key":"R11-16-20210129","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1046\/j.1365-2141.2002.03721.x","article-title":"Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: A survey of the European Group for Blood and Marrow Transplantation (EBMT).","volume":"118","author":"Ruutu","year":"2002","journal-title":"Br J Haematol"},{"key":"R12-16-20210129","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.bmt.1701359","article-title":"Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis.","volume":"22","author":"Paquette","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"R13-16-20210129","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.bmt.1702849","article-title":"Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: An analysis of associated conditions and clinical outcomes.","volume":"27","author":"Roy","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R14-16-20210129","first-page":"247","article-title":"Bone marrow transplant-associated thrombotic microangiopathy: A case series.","volume":"15","author":"Zeigler","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"R15-16-20210129","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1182\/blood.V77.8.1837.1837","article-title":"Hemolytic uremic syndrome following bone marrow transplantation in adults for hematologic malignancies.","volume":"77","author":"Rabinowe","year":"1991","journal-title":"Blood"},{"key":"R16-16-20210129","first-page":"271","article-title":"Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome following bone marrow transplantation.","volume":"16","author":"Sarode","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"R17-16-20210129","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.thj.6200127","article-title":"Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy.","volume":"2","author":"Arai","year":"2001","journal-title":"Hematol J"},{"key":"R18-16-20210129","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1182\/blood.V85.5.1391.bloodjournal8551391","article-title":"High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: A study by the North American Marrow Transplantation Group.","volume":"85","author":"Brown","year":"1995","journal-title":"Blood"},{"key":"R19-16-20210129","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJM198312013092202","article-title":"Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.","volume":"309","author":"Santos","year":"1983","journal-title":"N Engl J Med"},{"key":"R20-16-20210129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0277-5379(88)90298-2","article-title":"Chemotherapy with maximally tolerable doses of VP 16 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors.","volume":"24","author":"Mulder","year":"1988","journal-title":"Eur J Cancer Clin Oncol"},{"key":"R21-16-20210129","first-page":"21","article-title":"Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission.","volume":"3","author":"Helenglass","year":"1988","journal-title":"Bone Marrow Transplant"},{"key":"R22-16-20210129","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1182\/blood.V77.8.1660.1660","article-title":"Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: A randomized trial of two irradiation regimens.","volume":"77","author":"Clift","year":"1991","journal-title":"Blood"},{"key":"R23-16-20210129","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0140-6736(72)90292-9","article-title":"Aplastic anaemia treated by marrow transplantation.","volume":"1","author":"Thomas","year":"1972","journal-title":"Lancet"},{"key":"R24-16-20210129","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1083-8791(99)70008-X","article-title":"Thiotepa associated cardiomyopathy during blood or marrow transplantation: Associated with female sex and cardiac risk factors.","volume":"5","author":"Alidina","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"R25-16-20210129","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V70.5.1382.1382","article-title":"Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen.","volume":"70","author":"Tutschka","year":"1987","journal-title":"Blood"},{"key":"R26-16-20210129","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1182\/blood.V97.3.631","article-title":"Melphalan and purine analog-containing preparative regimens: Reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.","volume":"97","author":"Giralt","year":"2001","journal-title":"Blood"},{"key":"R27-16-20210129","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood.V84.3.941.941","article-title":"Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.","volume":"84","author":"Storb","year":"1994","journal-title":"Blood"},{"key":"R28-16-20210129","first-page":"553","article-title":"Cyclosporine and methylprednisolone for prophylaxis of acute graft-versus-host disease.","volume":"3","author":"Shepherd","year":"1988","journal-title":"Bone Marrow Transplant"},{"key":"R29-16-20210129","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJM199310213291703","article-title":"Cyclosporine, methotrexate and prednisone compared with cyclosporine and prednisone for prophylaxis for acute graft-versus-host disease.","volume":"329","author":"Chao","year":"1993","journal-title":"N Engl J Med"},{"key":"R30-16-20210129","first-page":"102a","article-title":"Phase II clinical trial of OKT3 for acute graft-versus-host disease (GVHD) prophylaxis in allogeneic bone marrow transplantation (allo BMT) [abstract].","volume":"90","author":"Alam","year":"1997","journal-title":"Blood"},{"key":"R31-16-20210129","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V80.7.1838.1838","article-title":"Acute graft-versus-host disease: Analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.","volume":"80","author":"Nash","year":"1992","journal-title":"Blood"},{"key":"R32-16-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2141.1988.tb02372.x","article-title":"Marrow transplantation from HLA non-identical family donors for the treatment of leukemia: A pilot study of 15 patients using additional immunosuppression and T-cell depletion.","volume":"69","author":"Cahn","year":"1988","journal-title":"Br J Haematol"},{"key":"R33-16-20210129","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A matched sibling donors.","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"R34-16-20210129","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bmt.1702854","article-title":"Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: Possible beneficial use of low molecular weight heparin.","volume":"27","author":"Simon","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R35-16-20210129","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura.","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"R36-16-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ajh.2830420214","article-title":"Effectiveness of cryosupernatant therapy in refractory and chronic relapsing thrombotic thrombocytopenic purpura.","volume":"42","author":"Obrador","year":"1993","journal-title":"Am J Hematol"},{"key":"R37-16-20210129","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/sim.4780120803","article-title":"Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?","volume":"12","author":"Pepe","year":"1993","journal-title":"Stat Med"},{"key":"R38-16-20210129","first-page":"1","article-title":"Analysis of survival data.","author":"Cox","year":"1984"},{"key":"R39-16-20210129","first-page":"80","article-title":"Bayesian statistics: An introduction.","author":"Lee","year":"1989"},{"key":"R40-16-20210129","first-page":"495","article-title":"Thrombotic microangiopathy following bone marrow transplantation.","volume":"14","author":"Pettitt","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"R41-16-20210129","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.bmt.1701928","article-title":"Calpain activity in bone marrow transplant-associated thrombotic thrombocytopenic purpura.","volume":"24","author":"Zeigler","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"R42-16-20210129","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.V73.7.2018.2018","article-title":"Microangiopathy in patients on cyclosporine prophylaxis who developed AGVHD after HLA identical bone marrow transplantation.","volume":"73","author":"Holler","year":"1989","journal-title":"Blood"},{"key":"R43-16-20210129","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bmt.1702648","article-title":"Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation.","volume":"26","author":"Uderzo","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R44-16-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1473-0502(02)00020-4","article-title":"Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver.","volume":"27","author":"Daly","year":"2002","journal-title":"Transfus Apheresis Sci"},{"key":"R45-16-20210129","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/00007890-199511000-00012","article-title":"Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.","volume":"60","author":"Kalhs","year":"1995","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.TP.0000141363.81600.0D","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:36:04Z","timestamp":1785850564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200411270-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,27]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000141363.81600.0d","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11,27]]}}}